Stronger Sell Today NBY ranks #4261 as SELL CANDIDATE #4261 Weaker Sell

NBY stock forecast NovaBay Pharmaceuticals, Inc

NBY stock forecast

VOLUME
Buy
TREND
Buy
MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Sell

NBY Forecast and Technical Stock Analysis

Sell candidate since 2019-07-16 Loss -18.68%

NovaBay Pharmaceuticals, Inc fell by -14.17% in the last day ( Thursday, 18th Jul 2019 ) from $1.26 to $1.08 and has now fallen 4 days in a row. During day the stock fluctuated 21.90% from a day low at $1.05 to a day high of $1.28. The price has fallen in 8 of the last 10 days and is down by -32.41% for this period. Volume has increased in the last day by 116 757 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 415 022 shares bought and sold for approximately $448 846.00.

Quick summary:

  • 30 day high of the NBY stock price was $2.24 and low was $1.05.
  • 90 day high was $4.04 and low was $0.23.
  • 52 week high for the NovaBay Pharmaceuticals, Inc - $4.04 and low - $0.23.
Top Trending Stocks

Trend

NovaBay Pharmaceuticals, Inc lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $0.92 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 47.57% during the next 3 months and, with 90% probability hold a price between $1.36 and $5.34 at the end of this period.

Top Golden Star Stocks

Signals

There are few to none technical positive signals at the moment. NovaBay Pharmaceuticals, Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $1.35 and $1.46. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday June 20, 2019, which indicates further falls until a new bottom pivot has been found. NovaBay Pharmaceuticals, Inc gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 11 and the stock is extremely oversold on RSI14, but some stocks may continue to fall despite the high chance of a correction up. The low RSI lowers the general risk and the stock should be considered if other technical requirements like liquidity and risk-reward are meet.

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Support & Resistance

NovaBay Pharmaceuticals, Inc finds support from accumulated volume at $1.04.

Support: $1.04 Price: $1.08 Resistance: $1.26

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.23 between high and low, or 21.90%. For the last week, the stock has had a daily average volatility of 10.63%.

NovaBay Pharmaceuticals, Inc is oversold on RSI14 (11). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buying opportunity.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

10.63 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Sell Candidate Upgraded

Evaluation

The NovaBay Pharmaceuticals, Inc stock holds several negative signals and despite the positive trend we believe NovaBay Pharmaceuticals, Inc will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.

Stronger Sell Today NBY ranks #4261 as SELL CANDIDATE #4261 Weaker Sell

Will NBY stock price go up or down on Mon, 22 Jul 2019?

Predict
Trading With Moving Average
As an investor, you always seek to understand what other... Full Article
Pivot Points
Pivot Points refer to points of significant change. As a... Full Article
Accumulated Volume - Support and Resistance
Volume is perhaps the best indicator of all and should... Full Article
Volume - The Indicator You Really Need to Know
Many new traders getting into the world of technical analysis... Full Article
We Give Back!
In 2016 StockInvest.us donated to NGO Goodwill projects to help purchase medical... Full Article
Better Buy: Amazon vs. Facebook
Amazon's stock slipped 21% over the past six months, as... Full Article

Proudly made at

ROCKIT